- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Anti-depressant
- Tianeptine
Population: Elderly
Individuals aged 65 years and above
- Adults
- General population
- Elderly
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Lifestyle intervention
- Education
- Therapeutic Exercise
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Plitidepsin
- Antineoplastic agent
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Pycnogenol
- Adults
- General population
- Elderly
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Neuromodulation
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19